mRNA Therapeutics - New applications for an old molecule

RNA, one of the oldest and most versatile biomolecules, has
recently entered the therapeutic arena. While for many observers
the success of mRNA vaccines seemed to come out of the blue, its
build on the fundament of research that has large gone ignored. Now
mRNA therapeutics are enjoying the limelight of great economic
success for companies like BioNTech / Pfizer and Moderna, and the
awarding of the 2023 Nobel Prize to two mRNA researchers. But with
the fame also comes a huge public backlash of anti-vaxxers who fear
the perceived novelty of mRNAs. In the 19th episode of We're
doomed, we're saved Louise von Stechow and Andreas Horchler talk
with their guest, mRNA researcher Lucia Lapazio who has known the
field before and after the hype.